Kiely Wealth Advisory Group, Inc. Astrazeneca PLC Transaction History
Kiely Wealth Advisory Group, Inc.
- $181 Billion
- Q2 2024
A detailed history of Kiely Wealth Advisory Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Kiely Wealth Advisory Group, Inc. holds 400 shares of AZN stock, worth $30,988. This represents 0.02% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$30,988
Previous $30.4 Million
7.59%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.03 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.3 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.14 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.84 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.36 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...